Day: July 30, 2021

What Delta has changed in the Covid pandemic — and what it hasn’t

In some respects, the Delta variant has changed everything in the Covid-19 pandemic. In others, the same rules still apply. Before the variant of SARS-CoV-2 began spreading rapidly in the United States, Covid-19 vaccines were drastically cutting the number of cases. They were preventing people from being infected. And vaccinated people who got infected were […]

FDA, under pressure, plans ‘sprint’ to accelerate review of Pfizer’s Covid-19 vaccine for full approval

WASHINGTON — Under heavy pressure, the Food and Drug Administration center that reviews vaccines is planning to deprioritize some of its existing work, like meetings with drug sponsors and plant inspections, in an effort to accelerate its review of Pfizer’s application for the formal approval of its Covid-19 vaccine, a senior agency official told STAT. […]

STAT+: Up and down the ladder: The latest comings and goings

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular […]

STAT+: Pharmalittle: Remdesivir props up Gilead’s declining fortunes; U.K. fines drug maker for price hikes

Good morning, one and all. Damian Garde here, filling in for Ed Silverman in the waning hours of another summer work week. At least in this part of the world, gray skies have given way to sunshine, and the weekend promises weather pleasant enough to convince even the most ocean-averse among us to give the […]

STAT+: Alzheimer’s scientists critique Cassava Sciences’ study results — overblown, inappropriate, uninterpretable

Independent researchers are expressing doubts about the purported benefits of an experimental treatment for Alzheimer’s from Cassava Sciences. The company said Thursday that a preliminary analysis of a small clinical trial showed its drug, called simufilam, improved the cognition of patients with Alzheimer’s disease — a benefit that no other treatment for Alzheimer’s has ever […]

States could get billions from opioid lawsuits. They have to decide how to spend it

The endgame of the sprawling mass of opioid lawsuits is starting to come into focus: Already, a settlement with Johnson & Johnson and three major drug distributors will pour billions of dollars into communities to combat the addiction crisis, with more to come. But what that looks like, exactly, will vary from place to place. […]

Overdose data, often scattered and siloed, pose challenges for researchers racing to predict risk

As fatal overdoses once again rise — accounting for 92,183 deaths in 2020, a 30% increase from the year before — public health researchers are racing to develop better tools to prevent them. Some see promise in models that pull in data and spit out predictions about who is at highest risk of developing opioid […]

Opinion: Smoothing the path to fighting food insecurity

Many Americans take good nutrition for granted. They shouldn’t. Hunger is a growing problem in the U.S. In 2019, more than 1 in every 10 American households suffered from food insecurity, meaning that they lacked access to enough food for an active, healthy life for all household members. The Covid-19 pandemic made things worse. The need […]

Opinion: Health care innovation can’t quit now that we are ahead

As health care companies raised a record-breaking $31.6 billion during the first quarter of 2021, investors drove home two big points: Health care providers adopted digital technologies like virtual care solutions in astonishing numbers as they pushed through the worst of the Covid-19 pandemic. Health care innovation is just getting started. I’ve never been more […]

Scroll to top